Act now: Resolving emerging IMIs worldwide
Experts discuss IMI diagnosis and management
Invasive mold infections (IMIs) remain a leading factor for morbidity and mortality, especially among immunosuppressed or critically ill patients, owing to its atypical clinical, radiological presentations and an expanding spectrum of immunocompromised hosts.
Last October, the World Health Organization published the first fungal priority pathogens list – the WHO FPPL – to strengthen the global response to this threat post-pandemic.
Join our panel of international experts in the latest AFWG Masterclass: The State of the Art in the Management of IMIs. Tailored for experienced clinicians, discover the latest cutting-edge insights, updates, and real-world challenges in the diagnosis and management of IMIs.
Start learning today: Click here
CME points are available in selected countries/regions.
